Sonja Wind

Deutsche Lufthansa AG’s cargo unit sees its Gulf rivals returning for a challenge just as new European Union parcel rules threaten a key e-commerce pipeline.

Bayer AG is putting its US glyphosate business into an entity called Ruveon, a move seen as an attempt to limit litigation risks tied to cancer claims over its Roundup weedkiller.

Bayer gliedert sein US-Glyphosatgeschäft in eine neue Einheit namens Ruveon aus. Der Schritt wird als Versuch gewertet, rechtliche Risiken im Zusammenhang mit Krebs-Klagen rund um das Unkrautvernichtungsmittel Roundup zu begrenzen.

Germany’s ruling coalition tweaked its cost-cutting reform bill for the country’s public health-insurance system in an effort to ease the financial impact on the pharmaceutical industry.

Hugo Boss AG recommended shareholders reject Frasers Group Plc’s takeover offer, saying the bid fails to capture the German fashion company’s long-term value.

Investigators probing the collapse of the front landing gear on a practically factory-fresh Boeing Co. jet in Frankfurt said a required locking pin wasn’t in place when the accident occurred last month.

German lawmakers approved a comprehensive overhaul of the country’s statutory health-insurance system that forces drug-price reductions on pharmaceutical companies as part of a wider drive to cut billions of euros in costs.

Der Bundestag hat eine umfassende Reform der gesetzlichen Krankenversicherung beschlossen. Sie verpflichtet Pharmaunternehmen zu höheren Preisnachlässen auf Medikamente und ist Teil eines umfassenderen Vorhabens, die Kosten um Milliarden Euro zu senken.

Boehringer Ingelheim GmbH’s new cancer pill Hernexeos, which helped buoy the German drugmaker’s first-half revenue, won’t go on sale in Europe until at least 2028, three years later than in the US.

AI can make mistakes, and that’s a red line in healthcare.